Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (380)
- Scheduling (national classification system) (164)
- Safety monitoring and information (26)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Medicinal cannabis hub (6)
- Clinical trials (5)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
751 result(s) found, displaying 201 to 225
-
Meeting statementsCommunique from the meeting of the TGACC
-
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsMeeting statement from the Advisory Committee on Medical Devices (ACMD), October 2022.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - November 2021 ACMS/ACCS meetings
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2022 ACMS/ACCS meetings
-
Corporate reportsDocuments released under the FOI Act in the 2021/22 financial year
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Corporate reportsThis Cost Recovery Implementation Statement provides information on how the TGA, within the Department of Health, implements and cost recovers its regulatory activities
-
Corporate reportsThe 2020-21 TGA Regulator Performance Report has now been published
-
Corporate reportsThe TGA Pharmacovigilance Inspection Program (PVIP) metrics report for 2021 is now available.
-
Scheduling decisions (final)Public notice of final decision to amend (or not to amend) the Poisons Standard, ACMS #37, ACCS #33, Joint ACMS-ACCS #30
-
Scheduling decisions (final)Public notice of final decision to amend (or not amend) the Poisons Standard, Joint ACMS-ACCS #29 in November 2021.
-
Corporate reportsTGA's Access Statement on Good Manufacturing Practice (GMP) Inspections Reliance and Recognition.
-
Meeting statementsAdvisory Committee on Vaccines, meeting 34, held 6 July 2022
-
Meeting statementsAdvisory Committee on Medicines meeting statement, Out of Session Meeting, 13 January 2022
-
Meeting statementsAdvisory Committee on Medicines meeting statement, Meeting 31, 3-4 February 2022
-
Meeting statementsAdvisory Committee on Medicines meeting statement, Meeting 32, 1 April 2022
-
Meeting statementsAdvisory Committee on Medicines meeting statement, Out of Session Meeting, 26 April 2022
-
Meeting statementsAdvisory Committee on Medicines meeting statement, Meeting 33, 2-3 June 2022
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 24 November 2022
-
Corporate reportsOverview of therapeutic goods advertising complaints handling and compliance for 2021-22